Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Income from Continuing Operations (2016 - 2025)

Medifast (MED) has disclosed Income from Continuing Operations for 16 consecutive years, with 18119000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 2376.26% year-over-year to 18119000.0, compared with a TTM value of 18672000.0 through Dec 2025, down 985.35%, and an annual FY2025 reading of 18672000.0, down 994.68% over the prior year.
  • Income from Continuing Operations was 18119000.0 for Q4 2025 at Medifast, down from 2254000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 46963000.0 in Q2 2021 and bottomed at 18119000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 19522550.0, with a median of 24825000.0 recorded in 2022.
  • Peak annual rise in Income from Continuing Operations hit 130.37% in 2025, while the deepest fall reached 2376.26% in 2025.
  • Year by year, Income from Continuing Operations stood at 34023000.0 in 2021, then dropped by 22.06% to 26519000.0 in 2022, then tumbled by 77.24% to 6036000.0 in 2023, then crashed by 86.81% to 796000.0 in 2024, then crashed by 2376.26% to 18119000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for MED at 18119000.0 in Q4 2025, 2254000.0 in Q3 2025, and 2475000.0 in Q2 2025.